Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kehui Meng"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
AimsAssessing the cost-effectiveness of Nivolumab with Gemcitabine–Cisplatin for Advanced Urothelial Carcinoma (aUC) treatment from the perspective of Chinese payers.MethodsA Markov model assessed economic outcomes, estimating health outcomes in qu
Externí odkaz:
https://doaj.org/article/29ca7c6012b541529e1081a680969feb
Autor:
Andong Li, Meiyu Wu, Ouyang Xie, Heng Xiang, Kehui Meng, Chongqing Tan, Long Wang, Xiaomin Wan
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Background and objectiveThe EV-302 trial found that the combination of enfortumab vedotin (EV) with pembrolizumab significantly improved survival for patients with metastatic urothelial carcinoma (mUC). However, given the high cost of the drugs, ther
Externí odkaz:
https://doaj.org/article/b4ce46e9beac4f228c31b672efce7fa8
Autor:
Kehui Meng, Xuan Liang, Suting Xue, Song Xu, Xudong Zheng, Zhidong Chen, Man Zhou, Zhongyu Li
Publikováno v:
Journal of Materials Science. 57:13903-13913
Without any chemical agent, gold nanosheets (AuNSs) were controllable synthesized through a facile photo-induced reduction within bacterial cellulose (BC) biopolymers. Compared with traditional polymers, AuNSs modified BC biopolymers (AuNSs@BC) biopo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582d4b41a0c30be33a479efab7b698a2
https://doi.org/10.1007/s10853-022-07273-x
https://doi.org/10.1007/s10853-022-07273-x